Molecular allergology

Defined Partial Allergen Diagnostics (DPA-Dx)

  • Determination of specific IgE against single allergen components in serum
  • Indication: ambiguous evidence, suspicion of multiple sensitizations or insufficient therapy success
  • Improves the risk assessment for severe reactions (anaphylaxis) and the choice of an optimal therapy
  • High quality of allergen components due to strict quality controls during the in-house production
  • Customized profiles designed for indication-specific analysis: multiple pollen, insect venom and pediatric allergies
  • Internal CCD marker enables differentiation between true poly-sensitizations and cross-reactions due to carbohydrates
  • Determination of the patient’s suitability for specific immunotherapy by identifying the allergy inducing component
  • Limited hands-on-time: fast and easy manual processing or highly efficient semi- and fully-automated processing using EUROBlotOne, EUROBlotMaster und EUROLineScan

Better safe than sorry with peanut allergy

  • Differentiation of “true“ peanut sensitisation (Ara h 1, Ara h 2, Ara h 3, Ara h 6, Ara h 7) from pollenassociated cross reactions (Ara h 5 and Bet v 1)
  • Well-founded risk assessment for severe and systemic reactions (anaphylaxis)
  • Targeted nutritional advice in cases of sensitisation to low-risk components (Ara h 5 and Ara h 8 / Bet v 1)
  • Only small amounts of serum (100 – 400 μl) required – ideal for paediatrics
  • Manual or fully automated processing
  • Standardised evaluation using EUROLineScan software